MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients

Cancer Research

Volumn 62, Issue 17, 2002, Pages 4955-4962

  Illmer, Thomas ^a   Schuler, Ulrich S ^a   Thiede, Christian ^a   Schwarz, Ute I ^a   Kim, Richard B ^b   Gotthard, Sebastian ^a   Freund, Daniel ^a   Schäkel, Ulrike ^a   Ehninger, Gerhard ^a   Schaich, Markus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CYTOGENETICS; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC RESISTANCE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALLELES; DNA, COMPLEMENTARY; EXONS; GENES, MDR; HUMANS; LEUKEMIA, MYELOID; LOGISTIC MODELS; MIDDLE AGED; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER; SURVIVAL RATE; VARIATION (GENETICS);

EID: 0036731995     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pharmacogenomics: Translating functional genomics into rational therapeutics
2. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
3. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
4. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
5. A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity
6. Expression of a multidrug-resistance gene in human tumors and tissues
7. HIV-1 protease inhibitors and the MDR1 multidrug transporter
8. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
9. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance
10. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: A Southwest Oncology Group Study
11. A Phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: A Southwest Oncology Group Study 9617
12. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML
13. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry
14. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression
15. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
16. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1
17. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein
18. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias
19. Gene rearrangement: A novel mechanism for MDR-1 gene activation
20. Genetic polymorphism in MDR-1: A tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors
21. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
22. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
23. Identification of functionally variant MDR1 alleles among European Americans and African Americans
24. Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia
25. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples
26. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice
27. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells
28. MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia
29. Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (mdr)-1 gene
30. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL
31. Cancer, p53, guardian of the genome